Open Beta
TREN
MetriLume
TREN

US marketsHUMA

SEC-sourced researchBeta

HUMA

Humacyte, Inc.

Company comparison ↗

Data passport

CIK
0001818382
Exchange
Nasdaq
Business activity
— · SIC 2836
Financial inputs
6/6
Filing date
Oct 7, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 0.0000 USD; December 2025: 2,038,000.0000 USD2M USD0 USD0December 2024December 2025
HUMA · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20240.0000Mar 27, 2026
December 20252,038,000.0000Mar 27, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20252,038,000.0000-40,833,000.0000-105,042,000.0000116,366,000.0000113,257,000.0000Mar 27, 2026
December 20240.0000-148,701,000.0000-98,122,000.0000137,872,000.0000190,541,000.0000Mar 27, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$2.04MDecember 2025Mar 27, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$0December 2024Mar 27, 202610-K
Net incomeNetIncomeLoss-$40.83MDecember 2025Mar 27, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$105.04MDecember 2025Mar 27, 202610-K
Total assetsAssets$116.37MDecember 2025Mar 27, 202610-K
Total liabilitiesLiabilities$113.26MDecember 2025Mar 27, 202610-K

New filings

Explore methodology ↗